Relypsa Announces New Employment Inducement Grants

Relypsa, Inc. RLYP, a biopharmaceutical company, today announced that on September 15, 2014, the compensation committee of the company's board of directors granted seven new employees options to purchase an aggregate of 63,500 shares of the company's common stock with a per share exercise price of $25.70, the closing trading price on the grant date. The stock options were granted pursuant to the Relypsa, Inc. 2014 Employment Commencement Incentive Plan, which was approved by the company's board of directors in June 2014 under Rule 5653(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the company.